← Leaderboards
Eliver Ghosn
Emory University
$2,574,051
Attributed
$2,804,484
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1M · FY2019–25$2M$1.5M$1M$500K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,804,484 · 4
By mechanism
R01$1,918,506 · 2
R21$885,978 · 2
Top collaborators
- Grace Yoonheekim Gombolay2 shared
Most similar at Emory University
Same institution · by research overlap
- Jeremy M. Boss$41,716,661
- Frances Eun-Hyung Lee$16,287,959
- Tongzhong Ju$2,768,494
- Jennifer C Felger$7,582,869
- Grace Yoonheekim Gombolay$1,500,738
Others in their field
Other Emerging Leaders on “Response”
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$195,683,539
- Kimberly Smith · Ppd Development Lp$115,671,664
- Paul F Gallagher · Woods Hole Oceanographic Institution$92,619,872
- Kevin Urdahl · Seattle Children'S Hospital$84,741,409
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$71,439,892
- Ted Ross · University Of Georgia$70,992,558
Research focus
ResponseInfectionImmune ResponsePhenotypeCellsAntibodies2019-NcovHigh DimensionalityCessation Of LifeSpecificityFlow CytometryAdultFutureAntibody ResponseCoronavirusCovid-19 MortalityBaseIgg3CohortCovid-19 PatientIgg2Igg4Antigen DetectionIga1
Grant awards (8)
Early Life B-cell and plasma cell development in the human Spleen: a new paradigm for lifelong immunity$778,829
R01 · FY2025 · AI · contact PI
Serological and cellular immune response to SARS-CoV-2 vaccination in pediatric multiple sclerosis on immunotherapy$259,468
R21 · FY2025 · AI
Serological and cellular immune response to SARS-CoV-2 vaccination in pediatric multiple sclerosis on immunotherapy$201,398
R21 · FY2024 · AI
flowBEAT: a multiparameter flow cytometry assay to discover longitudinal antibody responses associated with efficient recovery from COVID-19$192,880
R21 · FY2023 · AI · contact PI
flowBEAT: a multiparameter flow cytometry assay to discover longitudinal antibody responses associated with efficient recovery from COVID-19$232,232
R21 · FY2022 · AI · contact PI
Integrin-dependent modulation of macrophage function$390,000
R01 · FY2020 · AI · contact PI
Innate immune responses to SARS-CoV-2 in the lung and blood of patients with severe COVID-19$359,677
R01 · FY2020 · AI · contact PI
Integrin-dependent modulation of macrophage function$390,000
R01 · FY2019 · AI · contact PI